SWOG clinical trial number
SWOG-9312

Phase II Evaluation of Cisplatin + 5-FU + Radiation Therapy in Patients with Locally Advanced/Inoperable Bladder Cancer

Closed
Phase
Accrual
100%
Published
Abbreviated Title
Local Bladder
Activated
10/01/1993
Closed
04/01/1998

Research committees

Genitourinary Cancer

Publication Information Expand/Collapse

2001

Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group study

MHA Hussain;TR Glass;J Forman;W Sakr;DC Smith;M Al-Sarraf;J Jones;SP Balcerzak;ED Crawford;HB Grossman Journal of Urology 165:56-61

1999

Phase II evaluation of cisplatin + 5-fluorouracil + radiation therapy in patients with locally advanced/inoperable bladder cancer. A Southwest Oncology Group study 9312.

M Hussain;E Fisher;J Forman;W Sakr;A Drelichman;S Akhter;HB Grossman;ED Crawford Proc of the American Society of Clinical Oncology 18:333a(#1281)

Other Clinical Trials

SWOG Clinical Trial Number
S2427

Single Arm Phase II Study of Bladder Preservation with Immunoradiotherapy after a Clinically Meaningful Response to Neoadjuvant Therapy in Patients with Muscle Invasive Bladder Cancer (BRIGHT)
Research Committee(s)
Genitourinary Cancer
Activated
09/04/2025
Accrual
1%
Open
Phase
SWOG Clinical Trial Number
CCTG-PR26

A Randomized Phase III Clinical Trial for the Addition of Docetaxel to Androgen Receptor Pathway Inhibitors in Patients with Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response (TRIPLE-SWITCH)
Research Committee(s)
Genitourinary Cancer
Activated
01/30/2025
Open
Phase
SWOG Clinical Trial Number
S2312

A Phase III Study of Cabazitaxel with or without Carboplatin in Patients with metastatic castrate-resistant prostate cancer (mCRPC), Stratified by Aggressive Variant Signature
Research Committee(s)
Genitourinary Cancer
Activated
09/03/2024
Accrual
7%
Open
Phase